Results 141 to 150 of about 7,286 (173)
Some of the next articles are maybe not open access.

Normal Variant and Idiopathic Short Stature

2018
This chapter reviews normal variant short stature, comprised of both familial short stature (FSS) and constitutional delay of growth and puberty (CDGP), as well as idiopathic short stature (ISS). FSS and CDGP are physiologic variants of short stature without an organic cause. Although ISS is not a “normal variant” of short stature, as with FSS and CDGP
Penny M. Feldman, Mary M. Lee
openaire   +1 more source

Hormonal Treatment of Idiopathic Short Stature

Hormone Research in Paediatrics, 2007
<i>Background and Objective:</i> The classification idiopathic short stature (ISS) represents a heterogeneous group of children who, as a group, are similar in height to patients with growth hormone (GH) deficiency, Turner syndrome, and short stature as a consequence of being born small for gestational age.
openaire   +1 more source

Partial growth hormone insensitivity ‐ idiopathic short stature is not always idiopathic

Acta Paediatrica, 1999
Saenger P. Partial growth hormone insensitivity ‐ idiopathic short stature is not always idiopathic. Acta Pædiatr 1999; Suppl 428: 194–8. Stockholm. ISSN 0803–5326Heterozygous growth hormone receptor (GHR) gene defects are not a common cause of idiopathic short stature. Although some of these GHR mutations may result in relative insensitivity to growth
openaire   +2 more sources

Idiopathic Short Stature

New England Journal of Medicine, 2006
openaire   +2 more sources

[Growth hormone and idiopathic short stature].

Annales d'endocrinologie, 2009
Idiopathic short stature is defined by height below 3rd percentile, in a child with normal birth height and weight, lack of dysmorphy, endocrine deficiency or systemic disease. Food and Drugs administration approved GH treatment in this indication in the United States, because it induces height gain, and sometimes may increase quality of life. There is
F, Castinetti, C, Fabre-Brue, T, Brue
openaire   +1 more source

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy

Frontiers in Endocrinology, 2021
Martin Savage   +2 more
exaly  

Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment

Frontiers in Endocrinology, 2022
Hyun Wook Chae   +2 more
exaly  

Home - About - Disclaimer - Privacy